Clifford Chance has advised the joint sponsors CICC and CMBI on the deal. Mobvoi Inc. has completed the initial public offering and listing on the Main Board...
Mobvoi Inc.’s IPO on Hong Kong Stock Exchange
Sunshine Insurance’s HK$6.7 Billion IPO
Linklaters and King & Wood Mallesons advised the joint sponsors and underwriters in connection with the offering. Clifford Chance advised Beijing-based Sunshine Insurance Group. China’s Sunshine...
Tianqi Lithium’s Initial Public Offering
Zhong Lun, Latham & Watkins and Clayton Utz advised Tianqi Lithium on the offering. Clifford Chance advised the joint sponsors and the joint global coordinators. Tianqi...
Zhihu’s US$106 Million Hong Kong IPO and Dual Primary Listing
Skadden, Arps, Slate, Meagher & Flom LLP acted as legal advisers to Zhihu as to Hong Kong and US laws and Han Kun Law Offices as...
Arrail Group Limited’s US$88 Million Initial Public Offering
Harneys acted as British Virgin Islands and Cayman Islands counsel for the successful listing of the shares of Arrail Group Limited on the Main Board of...
Lepu Biopharma’s US$116.1 Million Hong Kong IPO and Listing
Clifford Chance has advised Lepu Biopharma Co., Ltd. on the deal. Herbert Smith Freehills has advised CICC and Morgan Stanley. The Joint Sponsors are CICC and...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
Zylox-Tonbridge’s US$330 Million IPO and Listing on the Hong Kong Stock Exchange
Davis Polk advised Zylox-Tonbridge Medical Technology Co., Ltd., while Clifford Chance has advised Morgan Stanley, CLSA and other underwriters. Grandall Advised Zylox-Tonbridge. JunHe advised Zylox-Tonbridge. The...